Sponsor Pipeline

GI Innovation, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07363057 A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of… Cancer Survivors Recruiting
Phase 1/2
NCT05824975 A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and… Advanced Solid Tumor Recruiting
NCT07172802 A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy… Advanced Solid Tumor Recruiting
NCT04977453 GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in… Advanced Solid Tumor Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Kidney Cancer (2) Bladder Cancer (1) Cervical Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Liver Cancer (1) Ovarian Cancer (1) Melanoma (1)
Get alerts when GI Innovation, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free